AbbVie news and events in 2026
AbbVie is a biopharmaceutical organization that discovers and develops medicines and healthcare solutions. The organization focuses its research and production on therapeutic areas including immunology, oncology, neuroscience, eye care, and aesthetics.
Public (ABBV)Pharmaceutical Manufacturing10,000+ employeesabbvie.comLinkedIn
Get AbbVie's live signals in Claude or ChatGPT, or by API
What changed at AbbVie this week? Use Autobound signals for abbvie.com.- Dated updates
- 112
- Last event
- Nov 17, 2026
- Open rolesSnapshot Nov 17, 2026
- 448
- Latest SEC filing
- Nov 3, 2026
Source: Autobound Signal API · 112 signals tracked for AbbVie · updated
Overview
AbbVie by topic
110-K filing
448open roles
62+signals
46 in the last 90 days
- X (Twitter)15+
- LinkedIn14
- Glassdoor13
- Reddit11
- and 3 more sources
Latest events
Latest AbbVie events
Showing 10 of 34 events. The Signal API returns all of them.
Get them with one API call- AwardLymphoma Research Foundation to Honor Leaders in Research, Patient Advocacy and Philanthropy at 2026 Annual GalaAbbVie will receive the Corporate Leadership Award from the Lymphoma Research Foundation at its 2026 Annual Gala.
- InvestmentPsiThera Closes $25 Million Financing to Advance Oral Therapeutics in ImmunologyAbbVie Ventures participated as a new investor in PsiThera's $25 million financing round, with Managing Director Claire Leurent joining PsiThera's Board of Directors.
- Facility expansionAbbVie expands Oxford R&D facility as part of £120 million-plus investmentAbbVie expanded its UK research and development facility in Oxford as part of an investment of more than £120 million.
- RevenueAbbVie Q3 Revenue Rises 10.3% to $17.4 Billion; Adjusted EPS Reaches $3.82AbbVie reported third-quarter 2026 revenue of $17.404 billion, an increase of 10.3% year over year.
- NewsAbbVie Reports Third-Quarter 2026 Financial ResultsWith Apogee Therapeutics
- In developmentAbbVie (ABBV) Seeks FDA Approval For Etentamig In Multiple MyelomaAbbVie submitted a Biologics License Application to the FDA for its multiple myeloma drug candidate etentamig.
- LaunchU.S. FDA Approves Subcutaneous Induction Regimen for AbbVie's SKYRIZI® (risankizumab-rzaa) for Adults With Moderately to Severely Active Crohn's DiseaseAbbVie announced that the U.S. FDA approved a subcutaneous induction regimen for SKYRIZI for adults with moderately to severely active Crohn's disease.
- In developmentAbbVie unveils positive Phase III results for lutikizumabAbbVie published positive Phase III results evaluating the efficacy and safety of its investigational drug lutikizumab.
- In developmentAbbVie (ABBV) Unveils Phase 2a Crohn's Data And Flags 2026 ESMO ReadoutsAbbVie reported Phase 2a trial data for its investigational dual-targeting Crohn's disease therapy ABBV-466.
- In developmentAbbVie's subcutaneous risankizumab meets Phase III AFFIRM endpointsAbbVie reported Phase III trial results for its subcutaneous induction regimen of risankizumab (Skyrizi) in patients with Crohn's disease.
Showing 10 of 34 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track AbbVie with the Signal API
One POST /v1/companies/enrich call with abbvie.com returns every signal type for AbbVie, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbvie.com","limit":20}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Companies related to AbbVie
AbbVie questions
What is the latest news on AbbVie?
What is going on with AbbVie?
Has AbbVie announced any acquisitions?
What else does Autobound track for AbbVie?
Is AbbVie hiring right now?
Page updated , the date of the newest row on this page.
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .